| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | China | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Taiwan | 2 | |
| #5 | United States | 2 | |
| #6 | Canada | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hu Guang | 13 |
| #2 | Yang Yongkun | 12 |
| #3 | Liu Junjian | 12 |
| #4 | Zhou Jianfeng | 11 |
| #5 | Wang Yuyu | 10 |
| #6 | Meng Guangrong | 10 |
| #7 | Gao Wenjing | 10 |
| #8 | Niu Panpan | 10 |
| #9 | Zhou Jian-Feng | 2 |
| #10 | Wang Yu-Yu | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020233589A1 | Fully human antibody targeting cd19 and application thereof | |
| WO2020200295A1 | Ex-vivo cultured macrophage population and use thereof | |
| WO2020025039A1 | T cell expressing chimeric antigen receptor, chimeric antigen-related expression vector and use thereof | |
| CA3074526A1 | Chimeric antigen receptor (car) binding to bcma and application thereof | |
| TW201934579A | A chimeric antigen receptor (CAR) binding to BCMA and use thereof |